publicEuropean Medicines Agency (EMA) · European Union · Updated Jun 5, 2026
EMA Updates Acceptable Intake Levels for Nitrosamine Impurities in Human Medicines
Manufacturers must verify that their products meet the newly established acceptable intake levels for nitrosamines and implement necessary quality control measures to keep impurities within limits.
Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Signal Management Lead
verifiedRegulatory action: Regulatory Update
Read impact briefarrow_forward